Viewing Study NCT00468351


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-06-20 @ 1:50 PM
Study NCT ID: NCT00468351
Status: UNKNOWN
Last Update Posted: 2007-05-02
First Post: 2007-05-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab for Refractory Diabetic Macular Edema (IBEME Study)
Sponsor: University of Sao Paulo
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetic Macular Edema View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bevacizumab View
None diabetes View
None intravitreal View
None macular edema View
None triamcinolone View
None VEGF View